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tions for Aboriginal people and Torres Strait
Islanders, it has some limitations.1 Many of
the intervention studies enrol predomi-
nantly moderately to highly nicotine-
dependent smokers and are conducted in
communities where smoking is no longer
the norm.2,3 Consequently, pharmacological
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Objectives:  To examine patterns of nicotine dependence, the value of the Fagerström 
Test for Nicotine Dependence (FTND) and its correlation with self-reported tobacco use 
and urinary cotinine concentrations among pregnant Indigenous women in Townsville.
Design, participants and setting:  Cross-sectional study of 201 consecutive women 
who self-reported tobacco use at their first antenatal visit to Townsville Aboriginal and 
er Health Service (TAIHS) between 1 November 2005 and 31 October 2007. All 
ers were to be assessed by FTND, and 108 women participating in the Tilly’s Tracks 
ct (a randomised trial of an intervention to reduce smoking in pregnant Aboriginal 
orres Strait Islander women) were to have a comprehensive smoking history taken 
rinary cotinine samples collected.
 outcome measures:  Self-reported smoking status, FTND scores and urinary 
ine concentrations.
Results:  Of 302 Indigenous women presenting to TAIHS, 201 (66.6%) identified as 
current tobacco users at their first antenatal visit; this proportion rose to 79.6% in women 
aged < 20 years. An FTND was completed for 152 women (75.6%), with a median score 
of 4, and 40.1% scoring 3 or less, indicating low levels of nicotine dependence. There 
were significant correlations between the FTND and number of cigarettes smoked 
(= 0.56; P < 0.001) and urinary cotinine concentrations (= 0.25; P = 0.030). Of those 
who provided comprehensive smoking histories, the median age of starting smoking 
was 15 years, with a median of two previous quit attempts; 71.4% reported partners who 
smoked and 27.3% reported smoking occurred inside the house.
Conclusion:  The use of the FTND in Indigenous pregnant women may assess physical 
nicotine dependence, thus providing information that will help in preparing quit-
smoking plans, including tailoring of pharmacological support to individual need. 
Quit-smoking programs that better address the behavioural and psychological aspects 
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of smoking within the Indigenous community in Australia are needed.m
inv
iouS oking cessation interventions,olving pharmacological, behav-ral and alternative therapies have
been extensively studied overseas and in
mainstream communities in Australia.
While evidence from these studies can influ-
ence the design of quit-smoking interven-
support has assumed an increasingly domi-
nant role in mainstream quit programs.
One of the factors in determining whether
an individual stops smoking is physical nic-
otine addiction. There are some data from
the Indigenous community that describe
motivation to quit and the contextual factors
in the environment that will affect the habit-
ual and psychological aspects of smoking,
but no data on physical addiction to nico-
tine.1,4 The Fagerström Test for Nicotine
Dependence (FTND) is a validated tool that
uses six short questions to assess a person’s
physical nicotine dependence.5 Its brevity
and reliability in predicting relapse6 has led
to it being widely used in the evaluation of
smoking cessation interventions, and its use
is recommended in Australian protocols.7
However, there is little evidence from within
the Indigenous community to inform its use.
We aimed to further investigate the ques-
tions of nicotine dependence and the useful-
ness of the FTND in the Indigenous
population. In conjunction with a ran-
domised trial of an intervention to reduce
smoking in pregnant Aboriginal and Torres
Strait Islander women (the Tilly’s Tracks
project), the staff of the Townsville Aborigi-
nal and Islander Health Service (TAIHS)
Mums and Babies program examined pat-
terns of nicotine dependence, the value of
the FTND, and its correlation with self-
reported tobacco use and urinary cotinine
concentrations among pregnant women
attending TAIHS for antenatal care.
METHODS
The Mums and Babies program, involving
antenatal care delivered by a mutidisciplin-
ary team, which commenced on 1 January
2000 in Townsville, Queensland, has been
described previously.8 From early 2005, all
women attending the Mums and Babies
program who reported tobacco use have
been assessed using the FTND to guide brief
interventions for tobacco use. In addition,
from 1 November 2005, women undergoing
baseline assessment for the Tilly’s Tracks
project9 provided a comprehensive smoking
history, including a 24-hour retrospective
diary detailing their personal smoking sta-
tus, their partner’s smoking habits, and
exposure to environmental tobacco smoke
in the home. This information was collected
at interview by trained Aboriginal health
workers, and was added to the routine
antenatal care activities included in a first
visit by the clinical team. Women also pro-
vided urine samples for cotinine testing.
In this study, we examined antenatal first-
visit data for all Indigenous women who
self-reported as smokers, and attended
TAIHS for antenatal care during the 2 years
between 1 November 2005 and 31 October
2007. In addition, we added a qualitative
component involving a focus group discus-
sion with Mums and Babies program staff to
evaluate the usefulness and ease of use of the
FTND in the context of day-to-day activity
in a busy primary care clinic.
Staff asked all women whether they iden-
tified as Aboriginal, Torres Strait Islander,
both Aboriginal and Torres Strait Islander, or
other identities.
Cotinine analysis was performed on urine
samples of the women who were involved in
the Tilly’s Tracks project. Analysis was by
enzyme-linked immunosorbent assay (ELISA)
(Cozart Microplate EIA, Cozart, Abingdon,
Oxfordshire, UK), as described previously.9 A
standard curve was generated for each analysis
run, and if the cotinine levels for both samples
in a duplicate pair were above the standardA • Volume 191 Number 10 • 16 November 2009
HEALTH CARErange, that sample was allocated the maximum
level from the standard curve for the run.
A comprehensive record of each preg-
nancy at TAIHS is recorded in a secure
database. The FTND data are included in
this data collection. All other Tilly’s Tracks
project data are held in a secure database at
the University of Newcastle.
Statistical analysis
Depending on their distribution, numerical
data are reported as mean and SD or median
and interquartile range (IQR). Bivariate
associations were tested using χ2, Kruskal–
Wallis and t tests, as appropriate. Spearman
rank correlation coefficients were calculated
to assess the correlation between the FTND
score and (i) numbers of cigarettes smoked
and (ii) the measured urinary cotinine con-
centration as assessed at the first visit.
All statistical tests were performed using
SPSS Version 17.0 for Windows (SPSS Inc,
Chicago, Ill, USA). A two-tailed P value
below 0.05 was regarded as significant.
Ethics approval
The smoking cessation project had the full
support of the community elected Board of
TAIHS. The Human Research Ethics Com-
mittee of the University of Newcastle
approved the research project. All women
gave written consent to participate.
RESULTS
Box 1 shows the derivation of the study
groups. Of the 302 pregnant Indigenous
women, 71.9% identified as Aboriginal,
17.2% as Torres Strait Islanders and 10.9% as
both, and 201 (66.6%) self-reported current
tobacco use at their first antenatal care visit.
The mean age of the 302 women was 25.6
years (SD, 5.9), with no difference between
smokers and non-smokers. Of the women
aged less than 20 years, 79.6% reported
current tobacco use (Box 2). The only char-
acteristic that differed between women who
did or did not complete an FTND was
alcohol use, with those not completing the
FTND being more likely to report risky
levels of drinking. There were no significant
differences in demographic characteristics
between the women in the Tilly’s Tracks
project who did and did not provide a
urinary sample for cotinine estimation.
Patterns of nicotine dependence
Of the 201 smokers, 152 (75.6%) completed
an FTND. The distribution of FTND
responses and scores is shown in Box 3. The
median FTND score was 4 (IQR, 2–9); 40.1%
of these pregnant smokers scored 3 or less on
the FTND. The FTND questions that corre-
lated best with the total FTND score were
Question 1 (How soon after you get out of
bed do you have a cigarette?) and Question 4
(the number of cigarettes smoked each day).
There was a significant positive correlation
between FTND score and number of ciga-
rettes smoked each day, with the number of
cigarettes smoked explaining 30.3% of the
variation in the FTND (Box 4, A).
Comprehensive smoking histories and 
cotinine levels
A comprehensive smoking history was
obtained for 99 women. The median age at
which they started smoking was 15 years
(IQR, 13–17; range, 9–32 years) and these
women had made a median of two previous
quit attempts (IQR, 1–3; range, 1–25). Of
the 77 participants with partners, 71.4%
had partners who smoked, 6.5% had part-
ners who were former smokers and 22.1%
had partners who had never smoked. Par-
ticipants cohabited with a median of two
1 Derivation of the 302 pregnant Indigenous women included in the study
TAIHS = Townsville Aboriginal and Islander Health Service. FTND = Fagerström Test for Nicotine 
Dependence. * The Tilly’s Tracks project included pregnant Indigenous women who: were smokers; agreed to 
participate; attended for their first antenatal care visit before 20 weeks’ gestation; were Townsville residents; 
did not have mental illness; and were not being treated for the use of any substance other than tobacco. ◆
First antenatal visit to TAIHS Mums and Babies program 
clinic, 1 November 2005 to 31 October, 2007
335
Smokers
201
Non-Indigenous women
33
Non-smokers
101
Not Tilly’s Tracks participants
93
(FTND, 47)
Tilly’s Tracks participants
108
(FTND, 105; 
detailed smoking history, 99;
urinary continine concentration, 73)
Tilly’s Tracks project* 
starts Nov 2005
2 Comparison of demographic and other characteristics for smokers and non-
smokers among 302 pregnant Australian Indigenous women attending the 
Mums and Babies program at the Townsville Aboriginal and Islander Health 
Service between 1 November 2005 and 31 October 2007
Characteristic
Total
(n = 302)
Non-smoker
(n = 101)
Smoker
(n = 201) P
Age < 20 years 17.6% 10.6% 21.2% 0.026
Single/separated/divorced 37.9% 36.0% 38.8% 0.636
Education to Year 10 or below 44.3% 29.3% 51.9% 0.001
Tobacco use 100% 33.4% 66.6%*
Alcohol use
Any 26.2% 9.9% 34.3% 0.001
Risky† 16.2% 4% 22.4% 0.001
Recreational drug use 13.9% 6.9% 17.4% 0.013
Domestic violence 9.9% 8.9% 10.4% 0.674
* Median, 10 cigarettes/day; interquartile range, 5–15 cigarettes/day. † Risky drinker according to national 
clinical guidelines, 2006.10 P < 0.05 significant. ◆MJA • Volume 191 Number 10 • 16 November 2009 555
HEALTH CAREsmokers (IQR, 1–3; range, 1–9), with
61.9% of households having three or more
smokers in residence (including the trial
participant). Smoking occurring mostly
outside the house was reported by 64.6% of
participants, while 27.3% reported that
smoking occurred both inside and outside
and 8.1% reported smoking mostly occur-
ring inside the house; 37.4% of participants
reported that smoking occurred inside the
car.
A first-visit urinary cotinine sample was
collected from 73 of the 108 women in the
Tilly’s Tracks project (67.6%), with a median
concentration of 3056.6ng/mL (IQR, 1068.9–
5858.7ng/mL). There was a significant posi-
tive correlation between FTND score and uri-
nary cotinine concentrations (Box 4, B).
Staff feedback
The experience of the TAIHS staff, particu-
larly that of Aboriginal Health Workers, indi-
cated that the FTND was easy and reasonably
quick to use, and readily incorporated into
daily workloads. Only Question 2 required
explanation (the term “abstain” was unfamil-
iar to some patients). Staff members felt that
the FTND gave them a good entry point to a
discussion about smoking in the context of
broaching such a discussion with women
from households with a certain amount of
social chaos, multiple resident smokers and
competing health priorities; staff also felt
women were honest in their answers. Staff
members also commented that they found
the scores provided a visual element to coun-
selling about the level of dependence on
nicotine and helped them to encourage quit
attempts during their brief intervention work.
DISCUSSION
Using the FTND, a well validated tool to
measure nicotine dependence, most preg-
nant Indigenous women in this study scored
in the lowest category, indicating a low to
medium physical dependence on nicotine.
Most smoking cessation guidelines sug-
gest that an assessment of nicotine depend-
ence should be made to guide individual
quit attempts.7,11,12 Use of the FTND in this
study was incorporated into the workflow of
a busy Indigenous maternal and child health
clinic. Feedback from health workers and
other staff was positive. They found the tool
simple to incorporate into daily clinical
work, easily understood and useful as an
“ice breaker”. The study shows significant
correlations between the number of cig-
arettes smoked and nicotine dependence
scores. The correlations of both the number
of cigarettes smoked and the time until the
first cigarette of the day — the two FTND
questions that comprise the Heavy Smoking
Index (HSI)11 — with the FTND score are to
be expected, but many women had low total
FTND scores, and the other FTND ques-
tions could potentially have been significant
contributors to the total FTND score. With
international evidence suggesting that rely-
ing solely on the number of cigarettes
smoked as an indicator of nicotine depend-
ence will underestimate the number of
patients with a high level of nicotine addic-
tion,13 the FTND or HSI may be useful in
primary care clinics.
The level of nicotine dependence in the
Indigenous community in Australia has not
been previously reported. Among the group
of Indigenous women in our study, 40%
scored 3 or lower on the FTND, indicating
low levels of physical nicotine dependence.
4 Correlations between Fagerström Test for Nicotine Dependence (FTND) score 
and (A) the reported number of cigarettes smoked (152 women), and (B) the 
urinary cotinine concentration measured (73 women) at the first antenatal visit 
to the Mums and Babies program clinic at the Townsville Aboriginal and 
Islander Health Service between 1 November 2005 and 31 October 2007
* If the data are reanalysed without the two outliers (reporting smoking 50 and 60 cigarettes/day), the 
Spearman rank correlation is ρ = 0.55; P < 0.001. † Cotinine concentration (ng/mL) categories were based on 
the percentiles of the original distribution of cotinine: 1,  300; 2, 301–800; 3, 801–1500; 4, 1501–2100; 5, 
2101–3000; 6, 3001–5000; 7, 5001–5750; 8, 5751–6000; 9, > 6000. ◆
A. Correlation between FTND score and  
 number of cigarettes smoked (152 women)
B. Correlation between FTND score and 
 urinary cotinine concentration (73 women)
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3 Patterns and distribution of nicotine dependence as assessed using the 
Fagerström Test of Nicotine Dependence (FTND) at the first antenatal visit for 
152 women attending the Mums and Babies program clinic at Townsville 
Aboriginal and Islander Health Service between November 1 2005 and 
October 31 2007
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HEALTH CAREThis distribution of scores is consistent with
findings of other studies in pregnant
women.14,15 It is possible that our cohort of
Indigenous women under-scored on the
FTND, as has been suggested in African
American teenagers.16 However, the credibil-
ity of these demonstrated lower levels of
nicotine dependence may be supported by
the current Indigenous tobacco narrative,
which includes suggestions that Indigenous
people cope without constant access to cig-
arettes,1 and an apparent failure of nicotine
replacement therapy (NRT) in the Northern
Territory.17 The NT trial showed that NRT
conferred little advantage over a brief inter-
vention alone, which was partly blamed on
inadequate resources and a low-intensity
intervention. However, the degree of nicotine
dependence was not reported in that study,
and it is possible that the nicotine depend-
ence of the participants may have been lower
than was assumed,4 which might have con-
tributed to the lack of efficacy of NRT.
Low levels of nicotine dependence among
Indigenous pregnant women has significant
implications for the implementation of quit-
smoking programs. Evidence suggests that
NRT is not of value in light smokers or those
with low nicotine dependence,18,19 which is
reflected in a number of smoking cessation
guidelines.7,12 This reinforces the need to
assess nicotine dependence. While pharmaco-
logical therapies are important, they are
expensive, have side effects, and their use must
be tailored to individual needs. The FTND
scores in this study suggest cessation programs
need to consider the smoking behaviours of
each Indigenous woman to develop individual
quit plans with strategies to counter the habit-
ual aspects of their smoking.
Our study had some limitations. The
cohort comprised pregnant women, and the
overall demographic characteristics of our
cohort were typical of Indigenous pregnant
women,8 so our sample was probably repre-
sentative of that group. However, our find-
ings may not be applicable to the non-
pregnant Indigenous community. The
FTND has previously been found to be
psychometrically sound and to correlate
strongly with cotinine levels;5,20 the signifi-
cant but weaker association found in this
group of women may be explained by a
number of factors. Nicotine metabolism in
pregnancy is accelerated, resulting in
reduced cotinine levels,21 and cigarette con-
sumption tends to vary throughout preg-
nancy.22 In addition, recording cotinine
levels using a maximum cut-off level is likely
to have underestimated the correlation
coefficient for FTND and cotinine level.
While cotinine levels are method-depend-
ent,20,23 those reported for these pregnant
women are comparable to levels found in
other reports.22,24 To further explore these
issues in the Indigenous Australian commu-
nity would require more rigorous investiga-
tion.
In conclusion, this study shows the use of
the FTND in Indigenous pregnant women
may assess physical nicotine dependence,
thus providing information that will help in
preparing quit-smoking plans. Tailored use
of pharmacological support must be assisted
by strategies to address habitual and psy-
chological aspects of smoking within the
Indigenous community in Australia.
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